Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Senti Biosciences, Inc. - Common Stock (NQ: SNTI )

0.9537 -0.0263 (-2.68%)
Streaming Delayed Price Updated: 2:04 PM EDT, Jun 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 12,152
Open 0.9500
Bid (Size) 0.9500 (1)
Ask (Size) 0.9630 (3)
Prev. Close 0.9800
Today's Range 0.9500 - 0.9899
52wk Range 0.8625 - 8.770
Shares Outstanding 2,166,356
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Senti Bio Highlights Initial Gene Circuit Data From Collaborations at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
Five presentations showcase the modularity and applicability of Senti’s Gene Circuit technology in NK cells, T cells, AAVs, iPSCs, and macrophages 
From Senti Biosciences, Inc.
Via GlobeNewswire
Senti Bio Announces First Quarter 2023 Results and Pipeline Updates
From Senti Biosciences, Inc.
Via GlobeNewswire

Performance

YTD
-35.56%
-35.56%
1 Month
-10.03%
-10.03%
3 Month
-29.36%
-29.36%
6 Month
-50.33%
-50.33%
1 Year
-84.91%
-84.91%

More News

Read More
Senti Bio Announces Multiple Data Presentations at the American Society of Gene and Cell Therapy 2023 Annual Meeting
From Senti Biosciences, Inc.
Via GlobeNewswire
Expert Ratings for Senti Biosciences
Via Benzinga
Senti Biosciences's Return On Capital Employed Insights
Via Benzinga
Chardan Capital Maintains Buy Rating for Senti Biosciences: Here's What You Need To Know
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Senti Bio Highlights Preclinical Data from Multiple Gene Circuit Enabled Cell Therapy Programs at Annual AACR Meeting
From Senti Biosciences, Inc.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Senti Bio to Participate in Upcoming Investor Conferences
From Senti Biosciences, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Senti Bioscience, Inc. (SNTI) Investigation
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Senti Biosciences Announces New Employment Inducement Grants
From Senti Biosciences, Inc.
Via GlobeNewswire
Senti Bio to Present at the SVB Securities Global Biopharma Conference
From Senti Biosciences, Inc.
Via GlobeNewswire
Amazon To Rally Around 29%? Here Are 10 Other Analyst Forecasts For Monday
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Senti Bio Announces Pipeline Prioritization to Focus on Logic Gated Cell Therapies; Updates Cash Runway Guidance
From Senti Biosciences, Inc.
Via GlobeNewswire
Senti Bio to Present at 41st Annual J.P. Morgan Healthcare Conference
From Senti Biosciences, Inc.
Via GlobeNewswire
Why Innate Pharma Shares Are Trading Higher By 24%; Here Are 34 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 50 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why Vallon Pharmaceuticals Shares Are Trading Higher By Over 150%; Here Are 29 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Senti Bio Highlights Preclinical Data from Logic-Gated Gene Circuit CAR-NK Cell Therapy SENTI-202 at ASH Annual Meeting and Investor Event
From Senti Biosciences, Inc.
Via GlobeNewswire
Senti Bio to Host Investor Event Highlighting SENTI-202 at the 2022 ASH Annual Meeting
From Senti Biosciences, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.